azithromycin for COVID-19 - living meta-analysis of clinical studies

meta|evidence COVID-19

Living systematic review and meta-analysis

vs. potential COVID-19 treatments
vs. control
vs. placebo
vs. standard of care

All
COVID 19 hospitalized
COVID 19 all comers
COVID-19 mild to moderate
COVID-19 severe or critically
COVID 19 outpatients
COVID-19 (hospitalized or not)
COVID-19 prophylaxis (children)
COVID-19 prophylaxis (excluding children)
infections other than COVID-19
Long COVID-19
preventing respiratory virus transmission
root
secondary prevention

Studies
Mapping
Meta-analysis
Excluded 1

table network network 2

display ongoing demontrated benefit only

popup

Rodriguez-Molinero, 2020

azithromycin vs. control

COVID 19 hospitalized

Rosenberg, 2020

azithromycin vs. control

COVID 19 hospitalized

DAWn-AZITHRO, 2021 2020-001614-38

azithromycin vs. standard of care

COVID 19 hospitalized

Sekhavati, 2020 IRCT20200415047092N1

azithromycin vs. standard of care

COVID 19 hospitalized

RECOVERY (AZI, Horby), 2020 NCT04381936

azithromycin vs. standard of care

COVID 19 hospitalized

NCT04613271, 0 NCT04613271

azithromycin vs. azithromycin

COVID-19 mild to moderate

COALITION I Covid-19 Brazil (AZI, Cavalcanti), 2020 NCT04322123

azithromycin vs. standard of care

COVID-19 mild to moderate

Espitia-Hernandez, 2020

azithromycin vs. standard of care

COVID-19 mild to moderate

Rashad A (AZI vs SoC), 2021

azithromycin vs. standard of care

COVID-19 mild to moderate

COALITION II Covid-19 Brazil (Furtado), 2020 NCT04321278

azithromycin vs. standard of care

COVID-19 severe or critically

Duke University azithromycin, 2020 NCT04335552

azithromycin vs. standard of care

COVID-19 severe or critically

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -

Extraction panel open

An extraction panel is open